The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Open accessAbstract
Background: Antiplatelet agents are the mainstay for secondary prevention of non-cardioembolic stroke. This systematic review examined the safety and efficacy of short-, middle-, and long-term aspirin in combination with clopidogrel as secondary prevention of stroke or transient ischemic attack (TIA) of presumed arterial origin. Methods: PubMed, EmBase, and CENTRAL were searched up to May 2014. Randomized controlled trials (RCTs) that compared aspirin plus clopidogrel versus aspirin or clopidogrel as secondary prevention of stroke or TIA of arterial origin were included. The analyses were stratified into short-term (≤3 months), middle-term (>3 months and <1 year), and long-term (≥1 year). Outcomes were compared using risk ratio (RR) and 95% confidence interval (95% CI). Results: Eight RCTs (20,728 patients) were included in the overall analysis. Compared with aspirin or clopidogrel alone, the complete analysis of all the data indicated that the combination therapy significantly reduced the risk of stroke recurrence (RR, 0.82; 95% CI 0.70-0.96, p = 0.01) and major vascular events (RR, 0.84; 95% CI 0.73-0.96, p < 0.01). But the risk of hemorrhagic stroke (RR, 1.59; 95% CI 1.08-2.33, p = 0.02) and major bleeding (RR, 1.83; 95% CI 1.37-2.45, p < 0.01) was increased. No RCT studied middle-term combination therapy. The analyses were therefore stratified into only two subgroups, short- and long-term treatment. Stratified analysis of short-term treatment showed that relative to monotherapy, the drug combination reduced the risk of stroke recurrence (RR, 0.69; 95% CI 0.59-0.81, p < 0.01) and did not increase the risk of hemorrhagic stroke (RR, 1.23; 95% CI 0.50-3.04, p = 0.65) and major bleeding events (RR, 2.17; 95% CI 0.18-25.71, p = 0.54). Short-term combination therapy was associated with a significantly lower risk of major vascular events (RR, 0.70; 95% CI 0.69 to 0.82, p < 0.01). Stratified analysis of long-term treatment revealed that the combination treatment did not decrease the risk of stroke recurrence (RR, 0.92; 95% CI 0.83-1.03, p = 0.15), but was associated with a significantly higher risk of hemorrhagic stroke (RR, 1.67; 95% CI 1.10-2.56, p = 0.02) and major bleeding events (RR, 1.90; 95% CI 1.46-2.48, p < 0.01). Long-term combination therapy failed to reduce the risk of major vascular events (RR, 0.92; 95% CI 0.84-1.03, p = 0.09). Conclusions: Compared with monotherapy, short-term aspirin in combination with clopidogrel is more effective as secondary prevention of stroke or TIA without increasing the risk of hemorrhagic stroke and major bleeding events. Long-term combination therapy does not reduce the risk of stroke recurrence, and is associated with increased major bleeding events. The clinical applicability of the findings of this systematic review, however, needs to be confirmed in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Hankey, G. J. (2004) · Cerebrovascular Diseases · doi:10.1159/000075299 · Cited by 35
Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials
Palacio, S., Hart, R. G., Pearce, L. A., Anderson, D. C., Sharma, M., Birnbaum, L., & Benavente, O. (2013) · International Journal of Stroke · doi:10.1111/ijs.12050 · Cited by 34
Southern Buenos Aires stroke project
Saposnik, G., González, L., Lepera, S., Luraschi, A. N., Sica, R. E. P., Caplan, L. R., & Rey, R. C. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00039.x · Cited by 33
Calcific aortic valve and spontaneous embolic stroke: A review of literature
Khetarpal, V., Mahajan, N., Madhavan, R., Batra, S., Mopala, P., Sagar, A., Rapolu, P., Nangia, S., & Afonso, L. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.018 · Cited by 32
How good is the Prevent model for estimating the health benefits of prevention?
Brønnum‐Hansen, H. (1999) · Journal of Epidemiology & Community Health · doi:10.1136/jech.53.5.300 · Cited by 31
Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke
Hankey, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1305127 · Cited by 28
Age threshold for vascular prophylaxis by aspirin in patients without diabetes
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., Fernando, D., & Idris, I. (2008) · Heart · doi:10.1136/hrt.2008.150698 · Cited by 21
Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke
Geraghty, O. C., Paul, N. L. M., Chandratheva, A., & Rothwell, P. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e242bb · Cited by 15
Survey of the causes of stroke among Mexican Americans in South Texas.
Worley, K. L., Lalonde, D. R., Kerr, D. R., Benavente, O., & Hart, R. G. (1998) · PubMed · Cited by 15
Willerson, J. T., Cable, G., & Yeh, E. T. H. (2009) · PubMed · Cited by 14
Diener, H., & Weber, R. (2013) · Stroke · doi:10.1161/strokeaha.112.680751 · Cited by 12
Research works printed but not linked: 8
- 10.1016/0140-6736(92)90608-6 · doi:10.1016/0140-6736(92)90608-6
- 10.1159/000236915 · doi:10.1159/000236915
- 10.1016/j.jstrokecerebrovasdis.2007.09.006 · doi:10.1016/j.jstrokecerebrovasdis.2007.09.006
- 10.1159/000121339 · doi:10.1159/000121339
- 10.1160/TH04-09-0559 · doi:10.1160/th04-09-0559
- 10.1016/j.clinthera.2008.02.006 · doi:10.1016/j.clinthera.2008.02.006
- 10.1371/journal.pone.0065754 · doi:10.1371/journal.pone.0065754
- 10.1016/j.jns.2013.06.025 · doi:10.1016/j.jns.2013.06.025
Cited by
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Self-citationArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
Metadata
- Authors
- Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C.
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2014-12-24
- Volume
- 39
- Issue
- 1
- Pages
- 13-22
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W1480729244
- Cited by
- 11,533
- References
- 211
- FWCI
- 181.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.